2,068 research outputs found
Growth behavior of Alicyclobacillus acidoterrestris as a function of strain and culture conditions
No full textAlicyclobacillus acidoterrestris is an acidophilic, spore-forming spoilage organism of concern for the fruit juice industry. The occurrence of bacterial spore-formers in low pH foods was thought to be insignificant. However, in recent years, spoilage of acidic juice by Alicyclobacillus was recognized and the seriousness of this situation began to be appreciated. A. acidoterrestris has been associated with commercially pasteurized fruit juices as well as other low pH, shelf-stable products such as bottled tea and isotonic drinks. It has been isolated from garden and forest soils and may be introduced into the manufacturing process through unwashed or poorly washed fruit. If spores are not destroyed by processing, they can germinate, grow, and spoil product. The purpose of this study was to develop an understanding of A. acidoterrestris growth as a function of strain, pH and temperature so that growth of A. acidoterrestris spores might be inhibited by environmental control and product formulation. Four strains of A. acidoterrestris were used to investigate the growth kinetics in response to pH (3.0, 4.0, 5.0) and temperatures (30, 37.5, 45ºC) by measuring the optical density (OD) every hour for 48 hours using a microtitre plate reader to develop the growth curves. The growth rates were calculated using the software program DMFit and were used to illustrate the relationship between the growth kinetics of A. acidoterrestris strains. When examining the generated data, we observed that there were some differences between growth kinetics of tested strains at various pH and temperature conditions. The differences were random and did not follow any specific trend. The use of a reference strain allows for greater availability and reproducibility. Accordingly, the ATCC 49025 strain is representative of the food isolates (strain N1100, N1102 and N1139) and can be used as a reference strain.M.S.Includes bibliographical referencesby Jennifer M. Merl
As Expectations for Libraries Evolve, How Can We Rise to the Challenge?
No full textHigher Ed 360 author Jennifer Leigh Hoyt interviewed Maletta Payne, Head Technology and Information Services Librarian and Associate Professor at Southern University and A&M College, and Laura Saunders, Professor and Associate Dean of the School of Library and Information Sciences at Simmons University, for the article As Expectations for Libraries Evolve, How Can We Rise to the Challenge
Cult: A Composite Novel
No full textCult (redacted)
The first component of the thesis is a composite novel called Cult which falls into two parts with seven narratives in each. Part 1 tracks the protagonist, Ellen, from her first involvement with the cult through to her eventually leaving it. Although fiction, the first half of the book answers the kinds of questions the author is asked when people discover that she was once a sannyasin (a follower of the guru Bhagwan Shree Rajneesh). While the experiences of meditation, group therapy and communal living are all faithfully rendered within the stories, the need for strong characters, narrative drive and a lightness of touch takes precedence.
Part 2 picks up Ellen’s story some twenty or so years later and explores what becomes of her in middle age. It also looks at other groups in society, such as academia, the law and the internet dating community which each have their own jargon, hierarchies, rituals and rules but are not considered to be cults.
The book examines the question raised in the Epigraph, ‘how do we be together when we feel so alone’ with a focus on relationships other than the familial and the romantic.
Collisions, Chasms and Connections: a Performative Exploration of the Composite Novel Form
The second part of the thesis is both a critical and creative response to three contemporary American books: Olive Kitteridge by Elizabeth Strout; A Visit from the Goon Squad by Jennifer Egan; and Legend of a Suicide by David Vann. The critical element comprises a close reading of the three books; a chronological reconstruction of their overarching storylines; and a consideration of what their authors have said about writing the books. It concludes that, in the composite novel, the simultaneous presentation of multiple views and storylines operate much like a 3D image to give the impression of depth to the characters and situations rendered. The creative element of the essay is a playful and personal response to the texts
Partner Facilitation and Partner Interference in Individuals' Weight Loss Goals
No full textDrawing on the logic of the relational turbulence model, this study examined the ways in which romantic partners facilitate and interfere with individuals’ weight loss goals. Participants (N = 122) described the ways in which their romantic partner had recently helped or hindered their weight loss at four times over the course of 2 months. We conducted a content analysis of responses to identify themes of partner facilitation (Research Question 1 [RQ1]) and partner interference (RQ2) in individuals’ weight loss goals. Results revealed seven themes of partner facilitation: (a) partner enabling diet, (b) motivation and encouragement, (c) emotional support and positive reinforcement, (d) exercising together, (e) partner enabling exercise, (f) dieting together, and (g) relationship influence and priorities. Four themes of partner interference emerged in the data: (a) inability to plan for healthy meals, (b) inability to control the food environment, (c) preventing or discouraging exercise, and (d) emotional or relational discouragement.Peer reviewe
sj-pdf-1-cep-10.1177_03331024221128250 - Supplemental material for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
No full textSupplemental material, sj-pdf-1-cep-10.1177_03331024221128250 for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial by Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan and Joel M Trugman in Cephalalgia</p
sj-pdf-2-cep-10.1177_03331024221128250 - Supplemental material for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
No full textSupplemental material, sj-pdf-2-cep-10.1177_03331024221128250 for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial by Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan and Joel M Trugman in Cephalalgia</p
sj-pdf-6-cep-10.1177_03331024221128250 - Supplemental material for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
No full textSupplemental material, sj-pdf-6-cep-10.1177_03331024221128250 for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial by Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan and Joel M Trugman in Cephalalgia</p
sj-pdf-4-cep-10.1177_03331024221128250 - Supplemental material for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
No full textSupplemental material, sj-pdf-4-cep-10.1177_03331024221128250 for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial by Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan and Joel M Trugman in Cephalalgia</p
sj-pdf-5-cep-10.1177_03331024221128250 - Supplemental material for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
No full textSupplemental material, sj-pdf-5-cep-10.1177_03331024221128250 for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial by Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan and Joel M Trugman in Cephalalgia</p
sj-pdf-3-cep-10.1177_03331024221128250 - Supplemental material for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
No full textSupplemental material, sj-pdf-3-cep-10.1177_03331024221128250 for Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial by Brad C Klein, Rosa Miceli, Lawrence Severt, Peter McAllister, Laszlo Mechtler, Jennifer McVige, Merle Diamond, Michael J Marmura, Hua Guo, Michelle Finnegan and Joel M Trugman in Cephalalgia</p
- …
